Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?

Haemostasis

Volumn 28, Issue 3-4, 1998, Pages 174-194

  Mulder, M ^a   Terwel, D ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; ApoE; Cerebral amyloid angiopathy; HDL; Lipid metabolism; Amyloid

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; PROTEOHEPARAN SULFATE;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CHOLESTEROL TRANSPORT; HUMAN; LIPOPROTEIN METABOLISM; MICROGLIA; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS;

EID: 0032468707     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022429     Document Type: Article

References (35)

1. Glenner GG: Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). Med Hypotheses 1979;5:1231-1236.
2. Alzheimer A: Ueber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr 1907;64:146-148.
3. Tomlinson BE, Blessed S, Roth M: Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242.
4. Terry RD, Katzman DR, Bick KL: Alzheimer Disease. New York, Raven, 1994.
5. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Cowing E, Ball MJ: Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:10836-10840.
6. Glenner GG, Wong CW: Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-890.
7. Allsop D, et al: Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease. Neurosci Lett 1986;68:252-256.
8. Joachim CL, Duffy LK, Morris JH, Selkoe DJ: Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res 1988;474:100-111.
9. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB: Characterization of beta-amyloid peptide from human cerebrospinal fluid. J Neurochem 1993;61:1965-1968.
10. Koudinov A, Matsubara E, Frangione B, Ghiso J: The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein E and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun 1994;205:1164-1171.
11. Tall AR: An overview of reverse cholesterol transport. Eur Heart J 1998;19:A31-A35.
12. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
13. Poirier J, Baccichet A, Dea D, Gauthier S: Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 1993;55:81-90.
14. Young ID, Ailles L, Narindrasorasak S, Tan R, Kisilevsky R: Localization of the basement membrane heparan sulphate proteoglycans in islet amyloid deposition type II diabetes mellitus. Arch Pathol Lab Med 1992;116:951-954.
15. Norling B, Westermark T, Westermark P: Immunohistochemical identification of heparan sulphate proteoglycan in secondary systemic amyloidosis. Clin Exp Immunol 1988;73:333-337.
16. Snow AD, Wight TN, Nochlin D, Koike Y, Kimata K, DeArmond SJ, Prusiner SB: Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Kreutzfeldt-Jakob disease and scrapie. Lab Invest 1990;63:601-611.
17. Stenstad T, Magnus JH, Husby G, Kolset SO: Purification of amyloid-associated heparan sulphate proteoglycans and galactosamine-glycan free chains from human tissues. Scand J Immunol 1993;3:227-235.
18. Perlmutter LS, Chui HC, Saperia D, Athanikar J: Microangiopathy and the colocalization of heparan sulphate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res 1990;508:13-19.
19. Wisniewski HM, Frangione B: Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.
20. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families. Science 1993;26:921-923.
21. Namba Y, Tononaga M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-166.
22. Fraser PE, Nguyen JT, Chin DT, Kirschner DA: Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions. J Neurochem 1992;59:1531-1540.
23. Bradbury MW, Lightman SL: The blood-brain interface. Eye 1990;4:249-254.
24. Goldstein GW, Betz AL: The blood-brain barrier. Sci Am 1986;255:74-83.
25. De la Torre JC: Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology 1997;43:26-43.
26. Hassler O: Arterial deformities in senile brain. Acta Neuropathol 1967;8:219-229.
27. Ravens JR: Vascular changes in the human senile brain. Adv Neurol 1978;20:487-501.
28. Tagliavini F, Ghiso J, Timmers WF, Giaccone G, Bugiani O, Frangione B: Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab Invest 1990;62:761-767.
29. Kalaria RN: Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther 1996;72:193-214.
30. Bueé L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM: Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 1994;87:469-480.
31. Miyakawa T, Shimoji A, Kuramoto R, Higuchi Y: The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch B Cell Pathol 1982;40:121-129.
32. Arai H, Sugai N, Noguchi I, Haga S, Ishii T, Makino Y, Kosaka K: An immunohistochemical study of beta-amyloid protein in Alzheimer-type dementia brains. J Neurol 1989;236:214-217.
33. Luthert PJ, Williams JA: A quantitative study of the coincidence of blood vessels and A4 protein in deposits in Alzheimer's disease. Neurosci Lett 1991;126:110-112.
34. Kawai M, Kalaria RN, Harik SI, Perry G: The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 1990;137:1435-1446.
35. Kisilevsky R, Fraser PE: A beta amyloidogenesis: Unique, or variation on a systemic theme? Crit Rev Biochem Mol Biol 1997;32:361-404.